2007
DOI: 10.1016/j.bone.2007.05.005
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological effects of tiludronate in horses after long-term immobilization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
45
1
5

Year Published

2011
2011
2021
2021

Publication Types

Select...
4
4
1

Relationship

0
9

Authors

Journals

citations
Cited by 49 publications
(52 citation statements)
references
References 23 publications
1
45
1
5
Order By: Relevance
“…There is evidence that administration of tiludronate to the horse decreases bone resorption [4]. There is evidence that administration of tiludronate to the horse decreases bone resorption [4].…”
Section: Introductionmentioning
confidence: 99%
“…There is evidence that administration of tiludronate to the horse decreases bone resorption [4]. There is evidence that administration of tiludronate to the horse decreases bone resorption [4].…”
Section: Introductionmentioning
confidence: 99%
“…378 Horses were immobilized for 8 weeks, followed by a 4-week remobilization period and an 8-week standardized findings and also indicate that bone deposition rate is increased with training. A study evaluated tiludronate, a bisphosphonate, on biochemical biomarkers of bone metabolism and on bone density and structure in a model of disuse osteoporosis induced by cast application in horses.…”
Section: Adaptation Of Bone To Increased Stressmentioning
confidence: 99%
“…Currently tiludronate (a bisphosphonate) is widely used for similar bone pathologies in horses (Denoix et al 2003, Schulze 2005, Delguste et al 2007). The most important mechanism of action of bisphosphonates is to regulate bone metabolism through inhibition of bone resorption (Fleisch 1998).…”
Section: Introductionmentioning
confidence: 99%